Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
22,717,723
-
Share change
-
-1,836,356
-
Total reported value
-
$1,389,309,843
-
Put/Call ratio
-
288%
-
Price per share
-
$61.24
-
Number of holders
-
440
-
Value change
-
-$126,515,786
-
Number of buys
-
145
-
Number of sells
-
292
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2021
As of 31 Dec 2021,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
440 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,717,723 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, WELLS FARGO & COMPANY/MN, Eversept Partners, LP, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, COMMONWEALTH EQUITY SERVICES, LLC, and JANE STREET GROUP, LLC.
This page lists
440
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.